Clinical Trials Browser

Phase 3 × INDUSTRY × brigatinib × Clear all

ALK+ Advanced NSCLC

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell